Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 1
1984 2
1985 3
1986 4
1987 3
1988 2
1989 2
1990 6
1991 1
1992 3
1993 6
1994 2
1995 6
1996 6
1997 1
1998 4
1999 5
2000 3
2001 2
2002 6
2003 2
2004 2
2005 4
2006 5
2007 5
2008 3
2009 4
2010 4
2011 4
2012 3
2013 11
2014 5
2015 8
2016 7
2017 8
2018 4
2019 5
2020 2
2021 2
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

148 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial.
Sojo-Dorado J, López-Hernández I, Rosso-Fernandez C, Morales IM, Palacios-Baena ZR, Hernández-Torres A, Merino de Lucas E, Escolà-Vergé L, Bereciartua E, García-Vázquez E, Pintado V, Boix-Palop L, Natera-Kindelán C, Sorlí L, Borrell N, Giner-Oncina L, Amador-Prous C, Shaw E, Jover-Saenz A, Molina J, Martínez-Alvarez RM, Dueñas CJ, Calvo-Montes J, Silva JT, Cárdenes MA, Lecuona M, Pomar V, Valiente de Santis L, Yagüe-Guirao G, Lobo-Acosta MA, Merino-Bohórquez V, Pascual A, Rodríguez-Baño J; REIPI-GEIRAS-FOREST group. Sojo-Dorado J, et al. JAMA Netw Open. 2022 Jan 4;5(1):e2137277. doi: 10.1001/jamanetworkopen.2021.37277. JAMA Netw Open. 2022. PMID: 35024838 Free PMC article. Clinical Trial.
Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant Staphylococcus aureus Bacteremia and Endocarditis: A Randomized Clinical Trial.
Pujol M, Miró JM, Shaw E, Aguado JM, San-Juan R, Puig-Asensio M, Pigrau C, Calbo E, Montejo M, Rodriguez-Álvarez R, Garcia-Pais MJ, Pintado V, Escudero-Sánchez R, Lopez-Contreras J, Morata L, Montero M, Andrés M, Pasquau J, Arenas MD, Padilla B, Murillas J, Jover-Sáenz A, López-Cortes LE, García-Pardo G, Gasch O, Videla S, Hereu P, Tebé C, Pallarès N, Sanllorente M, Domínguez MÁ, Càmara J, Ferrer A, Padullés A, Cuervo G, Carratalà J; MRSA Bacteremia (BACSARM) Trial Investigators. Pujol M, et al. Clin Infect Dis. 2021 May 4;72(9):1517-1525. doi: 10.1093/cid/ciaa1081. Clin Infect Dis. 2021. PMID: 32725216 Free PMC article. Clinical Trial.
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study.
Gutiérrez-Gutiérrez B, Salamanca E, de Cueto M, Hsueh PR, Viale P, Paño-Pardo JR, Venditti M, Tumbarello M, Daikos G, Cantón R, Doi Y, Tuon FF, Karaiskos I, Pérez-Nadales E, Schwaber MJ, Azap ÖK, Souli M, Roilides E, Pournaras S, Akova M, Pérez F, Bermejo J, Oliver A, Almela M, Lowman W, Almirante B, Bonomo RA, Carmeli Y, Paterson DL, Pascual A, Rodríguez-Baño J; REIPI/ESGBIS/INCREMENT Investigators. Gutiérrez-Gutiérrez B, et al. Lancet Infect Dis. 2017 Jul;17(7):726-734. doi: 10.1016/S1473-3099(17)30228-1. Epub 2017 Apr 22. Lancet Infect Dis. 2017. PMID: 28442293
[Interpretive reading of enterobacteria antibiograms].
Navarro F, Miró E, Mirelis B. Navarro F, et al. Among authors: mirelis b. Enferm Infecc Microbiol Clin. 2010 Nov;28(9):638-45. doi: 10.1016/j.eimc.2010.05.002. Epub 2010 Jul 1. Enferm Infecc Microbiol Clin. 2010. PMID: 20579780 Review. Spanish.
Prulifloxacin: a new antibacterial fluoroquinolone.
Prats G, Rossi V, Salvatori E, Mirelis B. Prats G, et al. Among authors: mirelis b. Expert Rev Anti Infect Ther. 2006 Feb;4(1):27-41. doi: 10.1586/14787210.4.1.27. Expert Rev Anti Infect Ther. 2006. PMID: 16441207 Review.
[Detection of resistance phenotypes in gram-negative bacteria].
Navarro F, Calvo J, Cantón R, Fernández-Cuenca F, Mirelis B. Navarro F, et al. Among authors: mirelis b. Enferm Infecc Microbiol Clin. 2011 Aug-Sep;29(7):524-34. doi: 10.1016/j.eimc.2011.03.011. Epub 2011 Jun 21. Enferm Infecc Microbiol Clin. 2011. PMID: 21696863 Review. Spanish.
Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems.
Cantón R, Oliver A, Alós JI, de Benito N, Bou G, Campos J, Calvo J, Canut A, Castillo J, Cercenado E, Domínguez MÁ, Fernández-Cuenca F, Guinea J, Larrosa N, Liñares J, López-Cerero L, López-Navas A, Marco F, Mirelis B, Moreno-Romo MÁ, Morosini MI, Navarro F, Oteo J, Pascual Á, Pérez-Trallero E, Pérez-Vázquez M, Soriano A, Torres C, Vila J, Martínez-Martínez L. Cantón R, et al. Among authors: mirelis b. Enferm Infecc Microbiol Clin (Engl Ed). 2020 Apr;38(4):182-187. doi: 10.1016/j.eimc.2019.01.017. Epub 2019 Mar 14. Enferm Infecc Microbiol Clin (Engl Ed). 2020. PMID: 30878313 Free article. Review. English, Spanish.
Is Colistin Susceptibility Testing Finally on the Right Track?
Prim N, Rivera A, Coll P, Mirelis B. Prim N, et al. Among authors: mirelis b. Antimicrob Agents Chemother. 2018 Mar 27;62(4):e02067-17. doi: 10.1128/AAC.02067-17. Print 2018 Apr. Antimicrob Agents Chemother. 2018. PMID: 29588356 Free PMC article. No abstract available.
Letter: Non-cholera vibrio septicemia and meningoencephalitis.
Prats G, Mirelis B, Pericas R, Verger G. Prats G, et al. Among authors: mirelis b. Ann Intern Med. 1975 Jun;82(6):848-9. doi: 10.7326/0003-4819-82-6-848_2. Ann Intern Med. 1975. PMID: 1138607 No abstract available.
148 results